NovAliX Articles
Drug discovery alliances for Boehringer and Horizon Discovery; and NovAliX with Kyowa Hakko
15 January 2013
NovAliX in drug discovery collaboration with Teijin Pharma
13 January 2012
France’s NovAliX acquires majority interest in Germany’s Graffinity
16 November 2010
Showing 1-3 of 3 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
